Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data.

Jessica Yu¹, Sachie Mochida¹, Michele Emery¹, Patrick Carroll¹, Justin Ko^1,2, Arash Mostaghimi^1,3

¹Hims & Hers Health, Inc, 2269 Chestnut Street, Suite 523, San Francisco, CA, 94123, United States, 1 6508048434.

²Department of Dermatology, Stanford University School of Medicine, Stanford, CA, United States.

³Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Topical minoxidil and oral finasteride are approved by the US Food and Drug Administration (FDA) for the treatment of male androgenetic alopecia (AGA). However, concerns about adverse events related to the use of oral finasteride have led to some apprehension about the treatment. Topical finasteride, though not FDA-approved, has demonstrated efficacy and safety in a limited number of c…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.